As of July 1, 2025, many Aetna standard commercial plans removed Zepbound from their formularies when prescribed for the purpose of weight management
Thats why LegitScript is trusted by the world's largest internet platforms, payments companies, and regulatory agencies.
**Before all virtual visits to discuss possible weight loss prescriptions, please contact your insurance company to find out which medications (if any) may be covered
Abstract The discovery, characterization, and clinical development of glucagon-like-peptide-1 (GLP-1) spans more than 30 years and includes contributions from multiple investigators, science recognized by the 2017 Harrington Award Prize for Innovation in Medicine
The initial Phase 1 PK clinical trial results are encouraging in establishing the drug's tolerability and dosing regimen, but further data from Phase 1b and subsequent trials will be necessary to determine its efficacy and full safety profile, particularly for the treatment of obesity and T2D